Malik Muna, Atiq Ayesha, Tahir Muhammad Junaid, Akhtar Fahd Kamal, Malik Muhammad Irfan, Hassan Wardah, Asad Khan Fatima Muhammad, Akram Iqra, Manhas Noraiz, Ullah Irfan, Asghar Muhammad Sohaib
Combined Military Hospital (CMH), Lahore, 54000, Pakistan.
Lahore General Hospital, Lahore, 54000, Pakistan.
Ann Med Surg (Lond). 2022 Jun;78:103894. doi: 10.1016/j.amsu.2022.103894. Epub 2022 Jun 4.
Adverse effects on the health and well-being changes may also express as a decreased sleep quality in COVID-19 patients. This study aimed to assess sleep quality among confirmed COVID-19 patients and the non-COVID-19 Pakistani population.
An online cross-sectional survey was conducted between April and September 2020 in Punjab province, Pakistan. Information about demographic characteristics, COVID-19 diseased status, prior knowledge about COVID-19, and sleep quality using the Pittsburgh Sleep Quality Index (PSQI) was collected.
A total of 597 participants were included in this study, 296 (49.6%) COVID-19 patients and 301(50.4%) non-COVID-19 population. The PQSI was used to measure seven distinct sleep components; subjective quality, latency, duration, efficiency, disturbances, medication, and daytime dysfunction. Where mean ± standard deviation (SD) were 0.96 ± 0.743, 1.47 ± 1.032, 0.97 ± 1.006, 0.61 ± 0.995, 1.13 ± 0.649, 0.23 ± 0.651, 1.02 ± 0.861 respectively in total population (N = 597). Sleep latency, sleep duration, and sleep efficiency did not show a significant difference in the T-Test. While sleep quality, sleep disturbances, sleep medication, and daytime dysfunction showed a significant difference between both populations.
In conclusion, we highlighted the poor sleep quality in COVID-19 patients as compared to the non-COVID-19 population
对健康和幸福感的不良影响也可能表现为新冠肺炎患者睡眠质量下降。本研究旨在评估确诊的新冠肺炎患者和非新冠肺炎巴基斯坦人群的睡眠质量。
2020年4月至9月在巴基斯坦旁遮普省进行了一项在线横断面调查。收集了有关人口统计学特征、新冠肺炎患病状况、对新冠肺炎的先前了解以及使用匹兹堡睡眠质量指数(PSQI)的睡眠质量的信息。
本研究共纳入597名参与者,其中296名(49.6%)为新冠肺炎患者,301名(50.4%)为非新冠肺炎人群。PSQI用于测量七个不同的睡眠成分:主观质量、入睡潜伏期、睡眠时间、睡眠效率、睡眠障碍、睡眠药物和日间功能障碍。在总人群(N = 597)中,其平均值±标准差(SD)分别为0.96±0.743、1.47±1.032、0.97±1.006、0.61±0.995、1.13±0.649、0.23±0.651、1.02±0.861。入睡潜伏期、睡眠时间和睡眠效率在T检验中未显示出显著差异。而睡眠质量、睡眠障碍、睡眠药物和日间功能障碍在两组人群之间存在显著差异。
总之,我们强调了新冠肺炎患者与非新冠肺炎人群相比睡眠质量较差。